These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32848710)

  • 1. Early Detection and Prevention of Alzheimer's Disease: Role of Oxidative Markers and Natural Antioxidants.
    Arslan J; Jamshed H; Qureshi H
    Front Aging Neurosci; 2020; 12():231. PubMed ID: 32848710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Enzymatic Antioxidants against Alzheimer's Disease: Prevention, Diagnosis and Therapy.
    Varesi A; Campagnoli LIM; Carrara A; Pola I; Floris E; Ricevuti G; Chirumbolo S; Pascale A
    Antioxidants (Basel); 2023 Jan; 12(1):. PubMed ID: 36671042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State.
    Belkacemi A; Ramassamy C
    J Alzheimers Dis; 2016; 50(4):981-98. PubMed ID: 26890747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
    Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
    Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant strategies for Alzheimer's disease.
    Grundman M; Grundman M; Delaney P
    Proc Nutr Soc; 2002 May; 61(2):191-202. PubMed ID: 12133201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current topics about mild cognitive impairment (MCI)].
    Yamamoto Y
    Seishin Shinkeigaku Zasshi; 2011; 113(6):584-92. PubMed ID: 21815470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of antioxidants and Alzheimer's disease.
    Frank B; Gupta S
    Ann Clin Psychiatry; 2005; 17(4):269-86. PubMed ID: 16402761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease.
    Baldeiras I; Santana I; Proença MT; Garrucho MH; Pascoal R; Rodrigues A; Duro D; Oliveira CR
    J Alzheimers Dis; 2008 Sep; 15(1):117-28. PubMed ID: 18780972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
    Schrag M; Mueller C; Zabel M; Crofton A; Kirsch WM; Ghribi O; Squitti R; Perry G
    Neurobiol Dis; 2013 Nov; 59():100-10. PubMed ID: 23867235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment.
    Baldeiras I; Santana I; Proença MT; Garrucho MH; Pascoal R; Rodrigues A; Duro D; Oliveira CR
    J Alzheimers Dis; 2010; 21(4):1165-77. PubMed ID: 21504121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases.
    Mandel S; Weinreb O; Amit T; Youdim MB
    J Neurochem; 2004 Mar; 88(6):1555-69. PubMed ID: 15009657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
    Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
    Reed TT; Pierce WM; Markesbery WR; Butterfield DA
    Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.